Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,384 | 1,618 | 1,796 | 6,015 | 1,865 |
| Operating Income | -1,384 | -1,618 | -1,796 | -6,015 | -1,865 |
| Other Income | 62 | 76 | 101 | 107 | 62 |
| Pre-tax Income | -1,322 | -1,542 | -1,695 | -5,908 | -1,803 |
| Net Income Continuous | -1,322 | -1,542 | -1,695 | -5,908 | -1,803 |
| Net Income Discontinuous | N/A | N/A | 1 | 13,474 | -2,378 |
| Net Income | $-1,322 | $-1,542 | $-1,694 | $7,566 | $-4,181 |
| EPS Basic Total Ops | -0.53 | -0.62 | -0.32 | 3.10 | -1.83 |
| EPS Basic Continuous Ops | -0.53 | -0.62 | -0.71 | -2.43 | -0.79 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.38 | 5.53 | -1.04 |
| EPS Diluted Total Ops | -0.53 | -0.62 | 0.06 | 2.72 | -1.83 |
| EPS Diluted Continuous Ops | -0.53 | -0.62 | -1.02 | -2.12 | -0.79 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 1.07 | 4.84 | -1.04 |
| EPS Diluted Before Non-Recurring Items | -0.53 | -0.62 | N/A | N/A | N/A |
| EBITDA(a) | $-1,384 | $-1,618 | $-1,796 | $-6,015 | $-1,865 |